{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:42:21Z","timestamp":1792687341719,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Biochemical Parasitology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.molbiopara.2015.11.003","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T06:18:57Z","timestamp":1448173137000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Thiol redox biology of trypanosomatids and potential targets for chemotherapy"],"prefix":"10.1016","volume":"206","author":[{"given":"Alejandro E.","family":"Leroux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Luise","family":"Krauth-Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molbiopara.2015.11.003_bib0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bmb\/lds031","article-title":"Management of trypanosomiasis and leishmaniasis","volume":"104","author":"Barrett","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0015","series-title":"Proteins and Proteomics of Leishmania and Trypanosoma","first-page":"43","article-title":"Selection of molecular targets for drug development against trypanosomatids","author":"Smirlis","year":"2014"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0020","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1126\/science.3883489","article-title":"Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids","volume":"227","author":"Fairlamb","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0025","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/anie.200300639","article-title":"Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia","volume":"44","author":"Krauth-Siegel","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1089\/ars.2011.4392","article-title":"Low-molecular-mass antioxidants in parasites","volume":"17","author":"Krauth-Siegel","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0035","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"167","article-title":"Trypanothione-Based Redox Metabolism of Trypanosomatids","author":"Comini","year":"2013"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0040","doi-asserted-by":"crossref","first-page":"39794","DOI":"10.1074\/jbc.M306306200","article-title":"Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme","volume":"278","author":"Huynh","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/EC.00015-14","article-title":"Genetic validation of Trypanosoma brucei glutathione synthetase as an essential enzyme","volume":"13","author":"Pratt","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0050","doi-asserted-by":"crossref","first-page":"e1003731","DOI":"10.1371\/journal.ppat.1003731","article-title":"A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity","volume":"9","author":"De Muylder","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2014.05.007","article-title":"Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum","volume":"73","author":"Sousa","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0060","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2004.02.008","article-title":"Validation of Trypanosoma brucei trypanothione synthetase as drug target","volume":"36","author":"Comini","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0065","doi-asserted-by":"crossref","first-page":"36137","DOI":"10.1074\/jbc.M109.045336","article-title":"Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis","volume":"284","author":"Torrie","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0070","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1073\/pnas.95.9.5311","article-title":"Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival","volume":"95","author":"Tovar","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2958.2000.01721.x","article-title":"Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress","volume":"35","author":"Krieger","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0080","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1089\/ars.2008.2050","article-title":"Peroxidases of trypanosomatids","volume":"10","author":"Castro","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0085","doi-asserted-by":"crossref","first-page":"e1004075","DOI":"10.1371\/journal.ppat.1004075","article-title":"Cytosolic peroxidases protect the lysosome of bloodstream african trypanosomes from iron-mediated membrane damage","volume":"10","author":"Hiller","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0090","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2174\/0929867311320210005","article-title":"Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery","volume":"20","author":"Bernardes","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2009.09.002","article-title":"Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi","volume":"169","author":"Jones","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S0031182013000103","article-title":"Use of clomipramine as chemotherapy of the chronic phase of Chagas disease","volume":"140","author":"Fauro","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.actatropica.2015.02.012","article-title":"Trypanothione reductase inhibitors: overview of the action of thioridazine in different stages of Chagas disease","volume":"145","author":"Lo Presti","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0110","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.01568-08","article-title":"Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity","volume":"53","author":"Holloway","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0115","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cmdc.200900097","article-title":"Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis","volume":"4","author":"Richardson","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0120","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/cmdc.200900262","article-title":"Investigation of trypanothione reductase as a drug target in Trypanosoma brucei","volume":"4","author":"Spinks","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0125","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijpara.2009.05.002","article-title":"Preparative enzymatic synthesis of trypanothione and trypanothione analogues","volume":"39","author":"Comini","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0130","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1021\/jm200312v","article-title":"Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography","volume":"54","author":"Patterson","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cmdc.201000442","article-title":"Synthesis and evaluation of indatraline-based inhibitors for trypanothione reductase","volume":"6","author":"Walton","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/cmdc.200900098","article-title":"Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl) piperidine (BTCP) analogues as inhibitors of trypanothione reductase","volume":"4","author":"Patterson","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cmdc.201000420","article-title":"Improved inhibitors of trypanothione reductase by combination of motifs: synthesis, inhibitory potency, binding mode, and antiprotozoal activities","volume":"6","author":"Eberle","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0150","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/cmdc.201402032","article-title":"Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase","volume":"9","author":"Persch","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0155","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/cmdc.201300176","article-title":"Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography","volume":"8","author":"Baiocco","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0160","doi-asserted-by":"crossref","first-page":"29493","DOI":"10.1074\/jbc.M403187200","article-title":"Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design","volume":"279","author":"Saravanamuthu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0165","doi-asserted-by":"crossref","first-page":"e0003773","DOI":"10.1371\/journal.pntd.0003773","article-title":"Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach","volume":"9","author":"Beig","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0170","doi-asserted-by":"crossref","first-page":"10490","DOI":"10.1021\/jm301112z","article-title":"Conjugation of quinones with natural polyamines: toward an expanded antitrypanosomatid profile","volume":"55","author":"Lizzi","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0175","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"405","article-title":"Redox-active agents in reactions involving the trypanothione\/trypanothione reductase-based system to fight kinetoplastidal parasites","author":"Gendron","year":"2013"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cmdc.201300399","article-title":"Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase\/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi","volume":"9","author":"Belluti","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0185","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2174\/156802611796575894","article-title":"Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives","volume":"11","author":"Wilkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0190","first-page":"86","article-title":"Antitrypanosomal isothiocyanate and thiocarbamate glycosides from Moringa peregrina","volume":"80","author":"Ayyari","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0195","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.M113.495101","article-title":"Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei","volume":"288","author":"Lu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0205","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/cb400800q","article-title":"Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity","volume":"9","author":"Sharlow","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2958.2009.06761.x","article-title":"Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods","volume":"74","author":"Wyllie","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0215","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"429","article-title":"Inhibition of trypanothione synthetase as a therapeutic concept","author":"Koch","year":"2013"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0220","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.biotechadv.2011.05.012","article-title":"The trypanothione system and the opportunities it offers to create drugs for the neglected kinetoplast diseases","volume":"30","author":"Floh\u00e9","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2014.06.020","article-title":"9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma","volume":"83","author":"Maiwald","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0230","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1515\/BC.2011.222","article-title":"Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani","volume":"392","author":"Saudagar","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0235","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1016\/j.bmc.2013.08.052","article-title":"Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei","volume":"21","author":"Zimmermann","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejpb.2013.08.014","article-title":"Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen","volume":"85","author":"Saudagar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0245","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"297","article-title":"Drug targets in Trypanosomal and Leishmanial pentose phosphate pathway","author":"Comini","year":"2013"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0250","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1074\/jbc.M110.214833","article-title":"Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism","volume":"286","author":"K\u00f6nig","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0255","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.1038\/srep09705","article-title":"Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking","volume":"5","author":"Brindisi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0260","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0265","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1074\/jbc.M111.338285","article-title":"High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin","volume":"287","author":"Fueller","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbagen.2014.10.029","article-title":"Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target","volume":"1850","author":"Gonzalez-Chavez","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bmcl.2013.10.003","article-title":"Drug discovery considerations in the development of covalent inhibitors","volume":"24","author":"Mah","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0285","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/j.1742-4658.2012.08557.x","article-title":"Drug target validation of the trypanothione pathway enzymes through metabolic modelling","volume":"279","author":"Olin-Sandoval","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0290","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pena","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molbiopara.2015.11.003_bib0295","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."}],"container-title":["Molecular and Biochemical Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685115300396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685115300396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:18:41Z","timestamp":1718209121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166685115300396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0166685115300396"],"URL":"https:\/\/doi.org\/10.1016\/j.molbiopara.2015.11.003","relation":{},"ISSN":["0166-6851"],"issn-type":[{"value":"0166-6851","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiol redox biology of trypanosomatids and potential targets for chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular and Biochemical Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molbiopara.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}